Aldeyra Therapeutics, Inc. (ALDX) closed the last trading session at $5.43, gaining 28.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $9 indicates a 65.8% upside potential.The mean estimate comprises five short-term price targets with a standard deviation of $1.22. While the lowest estimate of $7.00 indicates a 28.9% increase from the current price level, the most optimistic an ...

Atle Fund Management AB grew its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 6.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 78,169 shares of the biopharmaceutical company’s stock after buying an additional 5,004 shares during the period. Gilead Sciences accounts for about 3.4% of Atle Fund Management AB’s investment portfolio, making the stock its 10th biggest holding. Atle ...

Group 1 - Betterware de Mexico SAPI de C (BWMX) shares have increased by 33.4% over the past four weeks, closing at $18.22, with a mean price target of $23.33 indicating a potential upside of 28.1% [1] - The average price targets range from a low of $20.00 to a high of $30.00, with a standard deviation of $5.77, suggesting a variability in estimates; the lowest estimate indicates a 9.8% increase, while the highest suggests a 64.7% upside [2] - Analysts show strong agreement on BWMX's ability to report better earnings than previously predicted, which supports the view of potential upside [4][11] Group 2 - The Zacks Consensus Estimate for BWMX has increased by 38% due to one estimate moving higher over the last 30 days without any negative revisions [12] - BWMX holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential upside [13] - While the consensus price target may not be a reliable indicator of the extent of BWMX's gains, it does provide a directional guide for price movement [14]

Core Viewpoint - UP Fintech Holding Limited (TIGR) shows potential for significant upside, with a mean price target of $13.31 indicating a 46.3% increase from its current price of $9.1 [1] Price Targets - The average price target consists of six estimates ranging from a low of $4.73 to a high of $17.50, with a standard deviation of $4.69, indicating variability among analysts [2] - The lowest estimate suggests a potential decline of 48%, while the highest indicates a possible upside of 92.3% [2] Analyst Sentiment - Analysts are optimistic about TIGR's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which historically correlate with stock price movements [4][11] - Over the past 30 days, one earnings estimate has increased, leading to a 30% rise in the Zacks Consensus Estimate for the current year [12] Zacks Rank - TIGR holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting strong potential for upside [13] Price Movement Guidance - While the consensus price target may not be a reliable predictor of the extent of TIGR's gains, it does provide a useful indication of the expected direction of price movement [14]

Core Viewpoint - Ooma (OOMA) shares have increased by 2.1% recently, closing at $11.93, with analysts suggesting a potential upside of 56.2% based on a mean price target of $18.63 [1] Price Targets and Analyst Estimates - The mean price target consists of four short-term estimates with a standard deviation of $0.95, indicating variability among analysts; the lowest estimate is $18.00 (50.9% increase), while the highest is $20.00 (67.6% increase) [2] - A low standard deviation suggests a strong agreement among analysts regarding the stock's price direction, although it does not guarantee that the stock will reach the average target [9] Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about Ooma's earnings, with a positive trend in earnings estimate revisions, which historically correlates with stock price movements [11] - Over the past 30 days, one earnings estimate has increased, leading to a 5.1% rise in the Zacks Consensus Estimate for the current year [12] - Ooma holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] Caution on Price Targets - While price targets are commonly referenced by investors, they can often mislead; empirical research indicates that they rarely predict actual stock price movements accurately [7] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8] - Investors should approach price targets with skepticism and not rely solely on them for investment decisions [10]

Core Viewpoint - Quantum Computing Inc. (QUBT) shows potential for significant upside, with a mean price target of $17 indicating a 40.4% increase from its current price of $12.11, following an 11% gain over the past four weeks [1]. Price Targets and Analyst Estimates - The mean estimate consists of four short-term price targets with a standard deviation of $5.6, indicating variability among analysts; the lowest estimate is $12.00 (0.9% decline), while the highest is $25.00 (106.4% increase) [2]. - A low standard deviation suggests strong agreement among analysts regarding the stock's price direction, which can serve as a starting point for further research [9]. Earnings Estimates and Analyst Sentiment - Analysts have shown growing optimism about QUBT's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which correlates with near-term stock price movements [11]. - Over the past 30 days, one earnings estimate has increased, leading to a 5.3% rise in the Zacks Consensus Estimate for the current year [12]. Zacks Rank and Investment Potential - QUBT holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, suggesting a strong potential for upside in the near term [13].

Core Viewpoint - Microsoft (MSFT) shares have seen a 1% increase over the past four weeks, closing at $483.47, with a mean price target of $630.07 indicating a potential upside of 30.3% according to Wall Street analysts [1][2]. Price Targets and Analyst Estimates - The mean estimate consists of 44 short-term price targets with a standard deviation of $41.74, suggesting variability in analyst predictions. The lowest estimate is $490.00 (1.4% increase), while the highest is $700.00 (44.8% increase) [2]. - A low standard deviation indicates a high degree of agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9]. Earnings Estimates and Analyst Agreement - Analysts show strong agreement in revising earnings per share (EPS) estimates higher, which correlates with potential stock price increases. Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 0.2% with one estimate moving higher and no negative revisions [11][12]. - Microsoft holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential upside [13]. Caution on Price Targets - Solely relying on price targets for investment decisions may not be wise, as empirical research suggests that they often mislead investors. Analysts may set overly optimistic targets due to business incentives [3][7][8]. - While price targets should not be ignored, they should be approached with skepticism, as they may not accurately reflect the stock's potential gains [10].

Group 1: Stock Performance and Price Targets - Shares of Private Bancorp of America, Inc. (PBAM) have increased by 1.6% over the past four weeks, closing at $57.52, with a mean price target of $74.33 indicating a potential upside of 29.2% [1] - The average price targets range from a low of $70.00 to a high of $78.00, with a standard deviation of $4.04, suggesting a potential increase of 21.7% to 35.6% from the current price level [2] Group 2: Analyst Consensus and Earnings Estimates - Analysts show strong agreement in revising PBAM's earnings estimates higher, which is a positive indicator for potential stock upside, as trends in earnings estimate revisions correlate with near-term stock price movements [4][9] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 0.8%, with one estimate moving higher and no negative revisions [10] Group 3: Zacks Rank and Investment Implications - PBAM currently holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential upside in the near term [11] - While the consensus price target may not be a reliable indicator of the extent of PBAM's gains, it does provide a directional guide for price movement [12]

Core Viewpoint - Slide Insurance Holdings, Inc. (SLDE) has seen a 10.8% increase in share price over the past four weeks, closing at $18.36, with analysts suggesting a potential upside of 25.3% based on a mean price target of $23 [1]. Price Targets - The average price target consists of five estimates ranging from a low of $21.00 to a high of $25.00, with a standard deviation of $1.87, indicating a potential increase of 14.4% to 36.2% from the current price [2]. - A low standard deviation suggests a strong agreement among analysts regarding the price targets, which may indicate a more reliable consensus [2][9]. Analyst Sentiment - Analysts show strong agreement in revising earnings estimates higher for SLDE, which historically correlates with positive stock price movements [4][11]. - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 5.3%, with two estimates moving higher and no negative revisions [12]. Zacks Rank - SLDE holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, suggesting a strong potential for upside [13]. Caution on Price Targets - While price targets are a common metric for investors, relying solely on them can be misleading, as analysts may set overly optimistic targets due to business incentives [3][8][10].

Core Viewpoint - Ooma (OOMA) shares have increased by 5.5% recently, closing at $11.61, with analysts suggesting a potential upside of 60.5% based on a mean price target of $18.63 [1] Price Targets - The average price target consists of four estimates ranging from $18.00 to $20.00, with a standard deviation of $0.95, indicating a potential increase of 55% to 72.3% from the current price [2] - A low standard deviation suggests a strong agreement among analysts regarding the price targets, which can be a useful indicator for further research [2][9] Analyst Sentiment - Analysts are increasingly optimistic about Ooma's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which historically correlates with stock price movements [4][11] - Over the past 30 days, the Zacks Consensus Estimate for the current year has risen by 28.6%, with four estimates moving higher and no negative revisions [12] Zacks Rank - Ooma holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting a strong potential upside [13] Conclusion on Price Targets - While the consensus price target may not be a reliable measure of the stock's potential gain, it does provide a directional guide for price movement [14]